Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
als
Articles
3
From
2026-07-13 11:32:10+00
To
2026-07-22 12:30:00+00
Range
2026-07-08 14:04:25.8713+00 →
2026-08-07 14:04:25.8713+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| als | ORG | 3 | 📊 🔍 🧲 |
| fda | ORG | 2 | 📊 🔍 🧲 |
| GPE | 2 | 📊 🔍 🧲 | |
| 1 billion | MONEY | 1 | 📊 🔍 🧲 |
| ab science | ORG | 1 | 📊 🔍 🧲 |
| ab sciences | ORG | 1 | 📊 🔍 🧲 |
| ab8939 | PRODUCT | 1 | 📊 🔍 🧲 |
| abbvies venclexta | PRODUCT | 1 | 📊 🔍 🧲 |
| ada | ORG | 1 | 📊 🔍 🧲 |
| adaptive clinical trial design bloodbrain barrier cns drug development fda accelerated approval pharmacokinetics previous | ORG | 1 | 📊 🔍 🧲 |
| agency | ORG | 1 | 📊 🔍 🧲 |
| ai readiness starts | ORG | 1 | 📊 🔍 🧲 |
| alon bennoon | PERSON | 1 | 📊 🔍 🧲 |
| als news | ORG | 1 | 📊 🔍 🧲 |
| andrii yalanskyi | PERSON | 1 | 📊 🔍 🧲 |
| annex clinical corporation | ORG | 1 | 📊 🔍 🧲 |
| aria | ORG | 1 | 📊 🔍 🧲 |
| arletta pharma advances lybrido | PERSON | 1 | 📊 🔍 🧲 |
| avlayah | ORG | 1 | 📊 🔍 🧲 |
| bbb | ORG | 1 | 📊 🔍 🧲 |
| biospace | ORG | 1 | 📊 🔍 🧲 |
| cambridge | GPE | 1 | 📊 🔍 🧲 |
| canada | GPE | 1 | 📊 🔍 🧲 |
| canadian | NORP | 1 | 📊 🔍 🧲 |
| clinibiz | ORG | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-22 12:30:00+00 | Health |
|
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS | Analyze | NeuroSense | 😐 neutral | 0.0959 |
| 2026-07-19 06:40:39+00 | Science |
|
The Blood-Brain Barrier Has Been Breached. Is Clinical Trial Science Ready? | Analyze | Moe Alsumidaie | 😐 neutral | 0.0748 |
| 2026-07-13 11:32:10+00 | Science |
|
AB Science ends three studies in multiple sclerosis, other immune conditions | Analyze | https://www.biospace.com/tristan-manalac | 😐 neutral | 0.0696 |